| Patent Number |
Title Of Patent |
Date Issued |
| 8017392 |
Hox11+, CD45- cells and methods of organ regeneration using the same |
September 13, 2011 |
| The invention features methods for increasing or maintaining the number of functional cells of a predetermined type in a mammal (e.g., a human patient), for example, the insulin producing cells of the pancreas, liver cells, spleen cells, or bone cells, that has injured or damaged cells o |
| 6984380 |
Treatment of diseases involving faulty MHC class I antigen complex presentation |
January 10, 2006 |
| Methods of treating autoimmune diseases, such as diabetes, characterized by faulty MHC class I antigen complex presentation are disclosed which involve exposure of the immune system of an individual susceptible to such disease to correctly associated MHC class I antigen complexes. Such |
| 6844011 |
Methods for inhibiting rejection of transplanted tissue |
January 18, 2005 |
| A method for inhibiting rejection by a recipient animal of a transplanted tissue, said method comprising modifying, eliminating, or masking an antigen which, when present on the surface of a cell of said tissue, is capable of causing a T-lymphocyte-mediated response in said animal, to |
| 6660487 |
Treatment of autoimmune disease |
December 9, 2003 |
| The present invention features a novel combination therapy useful in the treatment of autoimmune disease that increases or maintains the number of functional cells of a predetermined type in a mammal by killing or inactivating autoimmune cells and re-educating the host immune system. |
| 6599710 |
Treatment of autoimmune disease |
July 29, 2003 |
| The present invention features a novel combination therapy useful in the treatment of autoimmune disease that increases or maintains the number of functional cells of a predetermined type in a mammal by killing or inactivating autoimmune cells and re-educating the host immune system. |
| 5783216 |
Methods for inhibiting rejection of transplanted tissue |
July 21, 1998 |
| A method for inhibiting rejection by a recipient animal of a transplanted tissue, said method comprising modifying, eliminating, or masking an antigen which, when present on the surface of a cell of said tissue, is capable of causing a T-lymphocyte-mediated response in said animal, to |
| 5538854 |
Method for the determination of predisposition to autoimmune disease |
July 23, 1996 |
| Described are methods for determining the predisposition of a mammal for developing an autoimmune disease that is characterized by defective presentation of self antigens on the surface of antigen presenting cells. The methods involve identifying defects in the processing, transport, or |
| 5538854 |
Method for the determination of predisposition to autoimmune disease |
July 23, 1996 |
| Described are methods for determining the predisposition of a mammal for developing an autoimmune disease that is characterized by defective presentation of self antigens on the surface of antigen presenting cells. The methods involve identifying defects in the processing, transport, or |
| 5283058 |
Methods for inhibiting rejection of transplanted tissue |
February 1, 1994 |
| A method for inhibiting rejection by a recipient animal of a transplanted tissue, said method comprising modifying, eliminating, or masking an antigen which, when present on the surface of a cell of said tissue, is capable of causing a T-lymphocyte-mediated response in said animal, to |
| 5139481 |
Treatment for type II diabetes |
August 18, 1992 |
| Disclosed is a method for treating insulin resistance in a patient which involves isolating a skeletal muscle cell from an insulin-sensitive donor and transplanting the skeletal muscle cell into the skeletal muscle tissue of the insulin-resistant patient. The transplanted cell may be a m |
